ArticleJournal of oncology practice2019
Financial Toxicity in Advanced and Metastatic Cancer: Overburdened and Underprepared.
Article in Journal of oncology practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
47 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Survivorship care for people affected by advanced or metastatic cancer: MASCC-ASCO standards and practice recommendations.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024Pooled it
- Reluctance to Accept Palliative Care and Recommendations for Improvement: Findings From Semi-Structured Interviews With Patients and Caregivers.The American journal of hospice & palliative care · 2022Trial
- Advanced cancer treatment decisions and their patient-facing financial burdens: a thematic analysis.The oncologist · 2026Article
- Association between time to treatment and financial toxicity among women with breast cancer in Ethiopia: a multicentre study in a low-resource setting.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- The Invisible Costs of Cancer Treatment: Quantifying Non-Medical Economic Consequences for Cancer Survivors Undergoing Systemic and Radiation Therapies.Cancer medicine · 2025Article
- Financial toxicity and associated factors among cancer patients attending public hospitals in Ethiopia.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Article
- Underserved Patient Populations With Metastatic Breast Cancer: A Review of Progress and Remaining Challenges.The breast journal · 2025Review
- Article
- "It is not the fault of the health care team - it is the way the system works": a mixed-methods quality improvement study of patients with advanced cancer and family members reveals challenges navigating a fragmented healthcare system and the administrative and financial burdens of care.BMC health services research · 2024Article
- Validity, test-retest reliability, and responsiveness of the Indonesian version of FACIT-COST measure for subjective financial toxicity.Health and quality of life outcomes · 2024Article
- The impact of socioeconomic inequality on access to health care for patients with advanced cancer: A qualitative study.Asia-Pacific journal of oncology nursing · 2024Article
- Financial Toxicity in Radiation Oncology.Cureus · 2024Review
- Comprehensive needs, social support, and disease perception in lung cancer patients treated with immune checkpoint inhibitors: a cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024Article
- Lay healthcare worker financial toxicity intervention: a pilot financial toxicity screening and referral program.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024Article
- Financial toxicity among people with metastatic cancer: findings from the Cancer Experience Registry.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024Article
- I'm still me, I'm still a person: war metaphor use and meaning making in women with metastatic breast cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024Article
- Level of caregiving burden and affecting factors in family caregivers of patients with lung cancer: A cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023Article
- Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patients.ESMO open · 2023Article
- The Role of Financial Difficulties as a Mediator between Physical Symptoms and Depression in Advanced Cancer Patients.Current oncology (Toronto, Ont.) · 2023Article
- Access Denied: Disparities in Thyroid Cancer Clinical Trials.Journal of the Endocrine Society · 2023Review
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
Abstract
Patients with metastatic or advanced cancer are likely to be particularly susceptible to financial hardship for reasons related both to the characteristics of metastatic disease and to the characteristics of the population living with metastatic disease. First, metastatic cancer is a resource-intensive condition with expensive treatment and consistent, high-intensity monitoring. Second, patients diagnosed with metastatic disease are disproportionately uninsured and low income and from racial or ethnic minority groups. These vulnerable subpopulations have higher cancer related financial burden even in earlier stages of illness, potentially resulting from fewer asset reserves, nonexisting or less generous health insurance benefits, and employment in jobs with less flexibility and fewer employment protections. This combination of high financial need and high financial vulnerability makes those with advanced cancer an important population for additional study. In this article, we summarize why financial toxicity is burdensome for patients with advanced disease; review prior work in the metastatic or advanced settings specifically; and close with implications and recommendations for research, practice, and policy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.